[18] Design of symmetry-based, peptidomimetic inhibitors of human immunodeficiency virus protease
- 1 January 1994
- book chapter
- Published by Elsevier
- Vol. 241, 334-354
- https://doi.org/10.1016/0076-6879(94)41072-0
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Inhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate. Synthesis and crystallographic analysisBiochemistry, 1993
- Diastereo‐ and Enantioselective Synthesis of C2‐Symmetrical HIV‐1 Protease InhibitorsAngewandte Chemie International Edition in English, 1993
- New hybrid transition state analog inhibitors of HIV protease with peripheric C2-symmetryTetrahedron Letters, 1992
- Stereocontrolled synthesis of C2-symmetric and pseudo-C2-symmetric diamino alcohols and diols for use in HIV protease inhibitorsThe Journal of Organic Chemistry, 1992
- The use of HIV-1 protease structure in inhibitor designBioorganic & Medicinal Chemistry Letters, 1992
- X-ray crystal structure of the HIV protease complex with L-700,417, an inhibitor with pseudo C2 symmetryJournal of the American Chemical Society, 1991
- Stereocontrolled synthesis of HIV-1 protease inhibitors with C2-axis of symmetryTetrahedron Letters, 1991
- Synthesis of (2S,5S,4R)-2,5-diamino-3,3-difluoro-1,6-diphenylhydroxyhexane: the core unit of a potent HIV proteinase inhibitorJournal of the Chemical Society, Chemical Communications, 1991
- Structure-based, C2 symmetric inhibitors of HIV proteaseJournal of Medicinal Chemistry, 1990
- Design, Activity, and 2.8 Å Crystal Structure of a C 2 Symmetric Inhibitor Complexed to HIV-1 ProteaseScience, 1990